Cellworks
Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Cellworks Information
Geographic Data
Address: 2033 Gateway Place Suite 500
City: San Jose
State: CA
Zip: 95110
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$15M
Raised Total:$33M
Social
Metrics
842,687Website Global Rank
33,589Website Monthly Traffic
Twitter Followers
Description
Cellworks Group operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and biomarker discovery and research in focused therapeutic areas. The company provides disease-focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cells with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and aging; and neurodegenerative. The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2009 | Series A | 1 | $3.5M |
Artiman Ventures Artiman Ventures |
6/2020 | Venture Round | $15.5M | 12/2012 | Series B | 2 | $13M |
Artiman Ventures Sequoia Capital Artiman Ventures Sequoia Capital |
3/2012 | Venture Round | $1M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
